In vitro evaluation of human intravenous immunoglobulin in combination with antimicrobials and human serum against multidrug-resistant isolates of Acinetobacter baumannii
The high incidence of multidrug-resistant (MDR) Acinetobacter baumannii has been a challenge for health worldwide, due to the reduction of therapeutic options, making the use of antimicrobial combinations necessary for the treatment, such as meropenem, amikacin, and colistin. Antibodies against bact...
Saved in:
Published in | Brazilian journal of microbiology Vol. 54; no. 4; pp. 2845 - 2856 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Cham
Springer International Publishing
01.12.2023
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The high incidence of multidrug-resistant (MDR)
Acinetobacter baumannii
has been a challenge for health worldwide, due to the reduction of therapeutic options, making the use of antimicrobial combinations necessary for the treatment, such as meropenem, amikacin, and colistin. Antibodies against bacterial species, mainly immunoglobulins G (IgG), are produced for acting as effector mechanisms (neutralization, opsonization, phagocytosis, and complement system activation). Some studies have demonstrated promising results of IgG in combination with antimicrobial preparations against bacterial infections, in which the direct action of IgG has restored the immune system balance. Serious problem caused by the increase of MDR
A. baumannii
isolates results in a constant search for therapeutic alternatives to defeat these infections. However, this study aims to verify
in vitro
the phagocytosis rate of the
A. baumannii
–infected human monocytes, as well as to analyze possible morphological changes induced by intravenous immunoglobulin G (IVIG) with human serum in association with antimicrobials. The phagocytosis rate and bacterial cell binding capacity of IVIG were determined for two
A. baumannii
isolates submitted to 4 mg/mL of human IVIG alone and in combination with different sub-minimum inhibitory concentrations (sub-MICs) of meropenem, amikacin, and colistin and processed for indirect immunofluorescence. Subsequently, these isolates were resubmitted and coupled with human serum and processed for scanning electron microscopy. There was no statistical difference for phagocytosis rates in the isolates tested. Bacterial isolates showed alterations in cell morphology when exposed to IVIG/human serum alone and in combination with antimicrobials such as alteration in shape, wrinkling, membrane depression, and especially cell rupture with extravasation of cytoplasmic material. The isolates visually differed in the IVIG binding to the bacterial cell, with higher fluorescence intensity, which corresponds to the highest IVIG binding, in the isolate more sensitive to meropenem, amikacin, and colistin. No differences between treatments were observed in the IVIG binding to the bacterial cell. The combined action of IVIG with meropenem, amikacin, and colistin against
A. baumannii
MDR isolates induced several bacterial cell damages. And when associated with human serum, a massive destruction of cells can be observed. These results may suggest the analysis of the use of IgG preparations for the treatment of
A. baumannii
MDR infections. |
---|---|
AbstractList | The high incidence of multidrug-resistant (MDR)
Acinetobacter baumannii
has been a challenge for health worldwide, due to the reduction of therapeutic options, making the use of antimicrobial combinations necessary for the treatment, such as meropenem, amikacin, and colistin. Antibodies against bacterial species, mainly immunoglobulins G (IgG), are produced for acting as effector mechanisms (neutralization, opsonization, phagocytosis, and complement system activation). Some studies have demonstrated promising results of IgG in combination with antimicrobial preparations against bacterial infections, in which the direct action of IgG has restored the immune system balance. Serious problem caused by the increase of MDR
A. baumannii
isolates results in a constant search for therapeutic alternatives to defeat these infections. However, this study aims to verify
in vitro
the phagocytosis rate of the
A. baumannii
–infected human monocytes, as well as to analyze possible morphological changes induced by intravenous immunoglobulin G (IVIG) with human serum in association with antimicrobials. The phagocytosis rate and bacterial cell binding capacity of IVIG were determined for two
A. baumannii
isolates submitted to 4 mg/mL of human IVIG alone and in combination with different sub-minimum inhibitory concentrations (sub-MICs) of meropenem, amikacin, and colistin and processed for indirect immunofluorescence. Subsequently, these isolates were resubmitted and coupled with human serum and processed for scanning electron microscopy. There was no statistical difference for phagocytosis rates in the isolates tested. Bacterial isolates showed alterations in cell morphology when exposed to IVIG/human serum alone and in combination with antimicrobials such as alteration in shape, wrinkling, membrane depression, and especially cell rupture with extravasation of cytoplasmic material. The isolates visually differed in the IVIG binding to the bacterial cell, with higher fluorescence intensity, which corresponds to the highest IVIG binding, in the isolate more sensitive to meropenem, amikacin, and colistin. No differences between treatments were observed in the IVIG binding to the bacterial cell. The combined action of IVIG with meropenem, amikacin, and colistin against
A. baumannii
MDR isolates induced several bacterial cell damages. And when associated with human serum, a massive destruction of cells can be observed. These results may suggest the analysis of the use of IgG preparations for the treatment of
A. baumannii
MDR infections. The high incidence of multidrug-resistant (MDR) Acinetobacter baumannii has been a challenge for health worldwide, due to the reduction of therapeutic options, making the use of antimicrobial combinations necessary for the treatment, such as meropenem, amikacin, and colistin. Antibodies against bacterial species, mainly immunoglobulins G (IgG), are produced for acting as effector mechanisms (neutralization, opsonization, phagocytosis, and complement system activation). Some studies have demonstrated promising results of IgG in combination with antimicrobial preparations against bacterial infections, in which the direct action of IgG has restored the immune system balance. Serious problem caused by the increase of MDR A. baumannii isolates results in a constant search for therapeutic alternatives to defeat these infections. However, this study aims to verify in vitro the phagocytosis rate of the A. baumannii–infected human monocytes, as well as to analyze possible morphological changes induced by intravenous immunoglobulin G (IVIG) with human serum in association with antimicrobials. The phagocytosis rate and bacterial cell binding capacity of IVIG were determined for two A. baumannii isolates submitted to 4 mg/mL of human IVIG alone and in combination with different sub-minimum inhibitory concentrations (sub-MICs) of meropenem, amikacin, and colistin and processed for indirect immunofluorescence. Subsequently, these isolates were resubmitted and coupled with human serum and processed for scanning electron microscopy. There was no statistical difference for phagocytosis rates in the isolates tested. Bacterial isolates showed alterations in cell morphology when exposed to IVIG/human serum alone and in combination with antimicrobials such as alteration in shape, wrinkling, membrane depression, and especially cell rupture with extravasation of cytoplasmic material. The isolates visually differed in the IVIG binding to the bacterial cell, with higher fluorescence intensity, which corresponds to the highest IVIG binding, in the isolate more sensitive to meropenem, amikacin, and colistin. No differences between treatments were observed in the IVIG binding to the bacterial cell. The combined action of IVIG with meropenem, amikacin, and colistin against A. baumannii MDR isolates induced several bacterial cell damages. And when associated with human serum, a massive destruction of cells can be observed. These results may suggest the analysis of the use of IgG preparations for the treatment of A. baumannii MDR infections. The high incidence of multidrug-resistant (MDR) Acinetobacter baumannii has been a challenge for health worldwide, due to the reduction of therapeutic options, making the use of antimicrobial combinations necessary for the treatment, such as meropenem, amikacin, and colistin. Antibodies against bacterial species, mainly immunoglobulins G (IgG), are produced for acting as effector mechanisms (neutralization, opsonization, phagocytosis, and complement system activation). Some studies have demonstrated promising results of IgG in combination with antimicrobial preparations against bacterial infections, in which the direct action of IgG has restored the immune system balance. Serious problem caused by the increase of MDR A. baumannii isolates results in a constant search for therapeutic alternatives to defeat these infections. However, this study aims to verify in vitro the phagocytosis rate of the A. baumannii-infected human monocytes, as well as to analyze possible morphological changes induced by intravenous immunoglobulin G (IVIG) with human serum in association with antimicrobials. The phagocytosis rate and bacterial cell binding capacity of IVIG were determined for two A. baumannii isolates submitted to 4 mg/mL of human IVIG alone and in combination with different sub-minimum inhibitory concentrations (sub-MICs) of meropenem, amikacin, and colistin and processed for indirect immunofluorescence. Subsequently, these isolates were resubmitted and coupled with human serum and processed for scanning electron microscopy. There was no statistical difference for phagocytosis rates in the isolates tested. Bacterial isolates showed alterations in cell morphology when exposed to IVIG/human serum alone and in combination with antimicrobials such as alteration in shape, wrinkling, membrane depression, and especially cell rupture with extravasation of cytoplasmic material. The isolates visually differed in the IVIG binding to the bacterial cell, with higher fluorescence intensity, which corresponds to the highest IVIG binding, in the isolate more sensitive to meropenem, amikacin, and colistin. No differences between treatments were observed in the IVIG binding to the bacterial cell. The combined action of IVIG with meropenem, amikacin, and colistin against A. baumannii MDR isolates induced several bacterial cell damages. And when associated with human serum, a massive destruction of cells can be observed. These results may suggest the analysis of the use of IgG preparations for the treatment of A. baumannii MDR infections. The high incidence of multidrug-resistant (MDR) Acinetobacter baumannii has been a challenge for health worldwide, due to the reduction of therapeutic options, making the use of antimicrobial combinations necessary for the treatment, such as meropenem, amikacin, and colistin. Antibodies against bacterial species, mainly immunoglobulins G (IgG), are produced for acting as effector mechanisms (neutralization, opsonization, phagocytosis, and complement system activation). Some studies have demonstrated promising results of IgG in combination with antimicrobial preparations against bacterial infections, in which the direct action of IgG has restored the immune system balance. Serious problem caused by the increase of MDR A. baumannii isolates results in a constant search for therapeutic alternatives to defeat these infections. However, this study aims to verify in vitro the phagocytosis rate of the A. baumannii-infected human monocytes, as well as to analyze possible morphological changes induced by intravenous immunoglobulin G (IVIG) with human serum in association with antimicrobials. The phagocytosis rate and bacterial cell binding capacity of IVIG were determined for two A. baumannii isolates submitted to 4 mg/mL of human IVIG alone and in combination with different sub-minimum inhibitory concentrations (sub-MICs) of meropenem, amikacin, and colistin and processed for indirect immunofluorescence. Subsequently, these isolates were resubmitted and coupled with human serum and processed for scanning electron microscopy. There was no statistical difference for phagocytosis rates in the isolates tested. Bacterial isolates showed alterations in cell morphology when exposed to IVIG/human serum alone and in combination with antimicrobials such as alteration in shape, wrinkling, membrane depression, and especially cell rupture with extravasation of cytoplasmic material. The isolates visually differed in the IVIG binding to the bacterial cell, with higher fluorescence intensity, which corresponds to the highest IVIG binding, in the isolate more sensitive to meropenem, amikacin, and colistin. No differences between treatments were observed in the IVIG binding to the bacterial cell. The combined action of IVIG with meropenem, amikacin, and colistin against A. baumannii MDR isolates induced several bacterial cell damages. And when associated with human serum, a massive destruction of cells can be observed. These results may suggest the analysis of the use of IgG preparations for the treatment of A. baumannii MDR infections.The high incidence of multidrug-resistant (MDR) Acinetobacter baumannii has been a challenge for health worldwide, due to the reduction of therapeutic options, making the use of antimicrobial combinations necessary for the treatment, such as meropenem, amikacin, and colistin. Antibodies against bacterial species, mainly immunoglobulins G (IgG), are produced for acting as effector mechanisms (neutralization, opsonization, phagocytosis, and complement system activation). Some studies have demonstrated promising results of IgG in combination with antimicrobial preparations against bacterial infections, in which the direct action of IgG has restored the immune system balance. Serious problem caused by the increase of MDR A. baumannii isolates results in a constant search for therapeutic alternatives to defeat these infections. However, this study aims to verify in vitro the phagocytosis rate of the A. baumannii-infected human monocytes, as well as to analyze possible morphological changes induced by intravenous immunoglobulin G (IVIG) with human serum in association with antimicrobials. The phagocytosis rate and bacterial cell binding capacity of IVIG were determined for two A. baumannii isolates submitted to 4 mg/mL of human IVIG alone and in combination with different sub-minimum inhibitory concentrations (sub-MICs) of meropenem, amikacin, and colistin and processed for indirect immunofluorescence. Subsequently, these isolates were resubmitted and coupled with human serum and processed for scanning electron microscopy. There was no statistical difference for phagocytosis rates in the isolates tested. Bacterial isolates showed alterations in cell morphology when exposed to IVIG/human serum alone and in combination with antimicrobials such as alteration in shape, wrinkling, membrane depression, and especially cell rupture with extravasation of cytoplasmic material. The isolates visually differed in the IVIG binding to the bacterial cell, with higher fluorescence intensity, which corresponds to the highest IVIG binding, in the isolate more sensitive to meropenem, amikacin, and colistin. No differences between treatments were observed in the IVIG binding to the bacterial cell. The combined action of IVIG with meropenem, amikacin, and colistin against A. baumannii MDR isolates induced several bacterial cell damages. And when associated with human serum, a massive destruction of cells can be observed. These results may suggest the analysis of the use of IgG preparations for the treatment of A. baumannii MDR infections. |
Author | de Freitas, Catarina Fernandes Veras, Dyana Leal de Araújo, Alberon Ribeiro Sandes, Jana Messias da Silva, Everton Morais Brayner, Fábio André do Nascimento, Amanda Vasconcelos de Lima, Fernanda Cristina Gomes Bezerra Cavalcanti, Carmelita de Lima Oliveira Júnior, Jorge Belém Alves, Luis Carlos |
Author_xml | – sequence: 1 givenname: Fernanda Cristina Gomes surname: de Lima fullname: de Lima, Fernanda Cristina Gomes organization: Central Laboratory of Public Health of Pernambuco – sequence: 2 givenname: Alberon Ribeiro surname: de Araújo fullname: de Araújo, Alberon Ribeiro organization: Laboratory of Molecular and Cellular Biology, and Laboratory of Leishmaniasis and Mutagenesis, Department of Parasitology, Aggeu Magalhães Institute (FIOCRUZ/PE) – sequence: 3 givenname: Amanda Vasconcelos surname: do Nascimento fullname: do Nascimento, Amanda Vasconcelos organization: Laboratory of Immunoparasitology, Aggeu Magalhães Institute (FIOCRUZ/PE) – sequence: 4 givenname: Carmelita de Lima surname: Bezerra Cavalcanti fullname: Bezerra Cavalcanti, Carmelita de Lima organization: Electronic Microscopy Laboratory, Keizo Asami Institute, Federal Universidad of Pernambuco – sequence: 5 givenname: Jorge Belém orcidid: 0000-0002-8130-1598 surname: Oliveira Júnior fullname: Oliveira Júnior, Jorge Belém email: junniorbiologia@gmail.com, junniorbiologia@hotmail.com organization: Laboratory of Molecular and Cellular Biology, and Laboratory of Leishmaniasis and Mutagenesis, Department of Parasitology, Aggeu Magalhães Institute (FIOCRUZ/PE) – sequence: 6 givenname: Jana Messias surname: Sandes fullname: Sandes, Jana Messias organization: Electronic Microscopy Laboratory, Keizo Asami Institute, Federal Universidad of Pernambuco – sequence: 7 givenname: Everton Morais surname: da Silva fullname: da Silva, Everton Morais organization: Bachelor’s Degree in Pharmacy From Federal Universidad of Pernambuco – sequence: 8 givenname: Catarina Fernandes surname: de Freitas fullname: de Freitas, Catarina Fernandes organization: Institute of Integral Medicine Professor Fernando Figueira (IMIP) – sequence: 9 givenname: Dyana Leal surname: Veras fullname: Veras, Dyana Leal organization: Laboratory of Molecular and Cellular Biology, and Laboratory of Leishmaniasis and Mutagenesis, Department of Parasitology, Aggeu Magalhães Institute (FIOCRUZ/PE) – sequence: 10 givenname: Luis Carlos surname: Alves fullname: Alves, Luis Carlos organization: Laboratory of Molecular and Cellular Biology, and Laboratory of Leishmaniasis and Mutagenesis, Department of Parasitology, Aggeu Magalhães Institute (FIOCRUZ/PE), Electronic Microscopy Laboratory, Keizo Asami Institute, Federal Universidad of Pernambuco – sequence: 11 givenname: Fábio André surname: Brayner fullname: Brayner, Fábio André organization: Laboratory of Molecular and Cellular Biology, and Laboratory of Leishmaniasis and Mutagenesis, Department of Parasitology, Aggeu Magalhães Institute (FIOCRUZ/PE), Electronic Microscopy Laboratory, Keizo Asami Institute, Federal Universidad of Pernambuco |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37904004$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Uslu1TAUjVARHeAHWCBLbNgErqfEWaGqYqhUiQ2sLSdx3rtVYhcPr-KX-Eoc8ijDgpVtneEOPufVifPOVtVzCq8pQPsmCta2UAPjNVAqeS0fVWe0aVUtBMiTcpe0rRVX7LQ6j_EWgEkQ7El1ytsOBIA4q75fO3LAFDyxBzNnk9A74ieyz4txBF0K5mCdz5HgsmTnd7Pv84wrRAa_9Og2yT2mPTEu4YJD8D2aOZbnePSJNuSFmJ1BFxNZ8pxwDHlXBxsxpiIjGP1sko1r7csBnU2-N0OygfRmtXCIT6vHU7G1z47nRfXl_bvPVx_rm08frq8ub-qhTJpqKu1kuDKdke3IgDWW2l5SEJTxXjHWiKkDKqABqRSltJkGJpToLe_oyIXiF9Xbzfcu94sdB7suYdZ3ARcTvmlvUP-NONzrnT9oCo3qOIfi8OroEPzXbGPSC8bBzrNxtqxSM6VE00rZiEJ9-Q_11ufgynyF1cm2dCnawmIbq-w2xmCnh24o6DULesuCLlnQP7OgZRG9-HOOB8mvzy8EvhFigdzOht-1_2P7A0M0xa4 |
Cites_doi | 10.2217/fmb.12.130 10.1016/j.jpba.2018.01.021 10.1128/AAC.00968-17 10.1002/jcla.20209 10.1128/AAC.00904-17 10.1055/s-0034-1398388 10.1086/514588 10.1016/j.micres.2021.126722 10.1007/s00018-016-2302-2 10.1016/j.micpath.2020.104529 10.12816/0046266 10.1016/j.cmi.2018.07.007 10.1089/mdr.2019.0243 10.1155/2002/127953 10.1006/cyto.1998.0435 10.1016/j.resmic.2018.04.005 10.1590/S1676-24442013000200002 10.1007/s10156-004-0325-3 10.1590/S0365-05962004000600002 10.2147/IDR.S120227 10.1016/j.biopha.2017.09.112 10.1099/jmm.0.000367 10.1128/CDLI.11.6.1158-1164.2004 10.1016/j.jmii.2019.08.007 10.1371/journal.pone.0210082 10.1128/iai.66.5.2279-2283.1998 10.1111/j.1365-2672.2009.04447.x 10.1590/1415-52732014000500005 10.1089/mdr.2019.0088 10.1007/s10156-010-0074-4 10.1007/s10096-013-1861-5 10.1093/femspd/ftx118 10.3389/fmicb.2016.00760 10.1179/1973947812Y.0000000032 |
ContentType | Journal Article |
Copyright | The Author(s) under exclusive licence to Sociedade Brasileira de Microbiologia 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2023. The Author(s) under exclusive licence to Sociedade Brasileira de Microbiologia. |
Copyright_xml | – notice: The Author(s) under exclusive licence to Sociedade Brasileira de Microbiologia 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2023. The Author(s) under exclusive licence to Sociedade Brasileira de Microbiologia. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QL 7U9 C1K H94 K9. M7N 7X8 5PM |
DOI | 10.1007/s42770-023-01153-5 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Bacteriology Abstracts (Microbiology B) Virology and AIDS Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Virology and AIDS Abstracts Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1678-4405 |
EndPage | 2856 |
ExternalDocumentID | 10_1007_s42770_023_01153_5 37904004 |
Genre | Journal Article |
GroupedDBID | 0R~ 0SF 23N 2WC 3V. 406 457 53G 5GY 5VS 6I. 6J9 7X7 7XC 88E 88I 8FE 8FH 8FI 8FJ AACTN AAEDW AAFGU AAFTH AAHNG AALRI AAPBV AATNV AAUYE AAXUO AAYFA ABECU ABFGW ABFTV ABJNI ABKAS ABKCH ABMAC ABMQK ABTEG ABTKH ABTMW ABUWG ABXHO ACBMV ACBRV ACBYP ACGFO ACGFS ACGOD ACHSB ACIGE ACIPQ ACOKC ACPRK ACTTH ACVWB ACWMK ADBBV ADFRT ADKNI ADMDM ADOXG ADTPH ADURQ ADYFF AEFTE AENEX AESKC AESTI AEVTX AEXQZ AFKRA AFNRJ AFQWF AFRAH AGDGC AGGBP AGHFR AGMZJ AHMBA AILAN AIMYW AITGF AITUG AJDOV AJZVZ AKQUC ALMA_UNASSIGNED_HOLDINGS AMKLP AMRAJ AMTXH AMXSW AMYLF AOIJS APOWU ATCPS AXYYD AZFZN AZQEC BAWUL BBNVY BCNDV BENPR BGNMA BHPHI BPHCQ BVXVI C1A CCPQU CLZPN CS3 CSCUP DIK DPUIP DU5 DWQXO E3Z EBLON EBS EJD FDB FNLPD FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IKXTQ IPNFZ IWAJR JZLTJ KOV KQ8 LK8 LLZTM M1P M2P M41 M4Y M7P M~E NCXOZ NPVJJ NQJWS NU0 O9- OK1 P2P PATMY PQQKQ PROAC PSQYO PT4 PYCSY RIG RNS ROL RPM RSC RSV SCD SNE SNPRN SOHCF SOJ SRMVM SSLCW SSZ TR2 UKHRP UOJIU UTJUX VEKWB VFIZW XSB ZMTXR AACDK AAHBH AAJBT AASML ABAKF ACAOD ACDTI ACZOJ ADVLN AEFQL AEMSY AFBBN AGQEE AIGIU AKRWK ALIPV CGR CUY CVF ECM EIF FIGPU NPM SJYHP AAYXX CITATION 7QL 7U9 C1K H94 K9. M7N 7X8 5PM |
ID | FETCH-LOGICAL-c382t-15efa38a9a57d2026e1eb5104123b82264f90140605881116fc2484be391d3483 |
ISSN | 1517-8382 1678-4405 |
IngestDate | Fri Nov 01 05:41:40 EDT 2024 Fri Nov 01 20:49:39 EDT 2024 Thu Oct 10 19:58:54 EDT 2024 Thu Sep 12 16:45:18 EDT 2024 Sat Nov 02 12:12:14 EDT 2024 Sat Dec 16 12:03:44 EST 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Intravenous immunoglobulin Scanning electron microscopy Indirect immunofluorescence Phagocytosis rates Acinetobacter baumannii |
Language | English |
License | 2023. The Author(s) under exclusive licence to Sociedade Brasileira de Microbiologia. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c382t-15efa38a9a57d2026e1eb5104123b82264f90140605881116fc2484be391d3483 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-8130-1598 |
PMID | 37904004 |
PQID | 2895760547 |
PQPubID | 1536339 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10689330 proquest_miscellaneous_2884675564 proquest_journals_2895760547 crossref_primary_10_1007_s42770_023_01153_5 pubmed_primary_37904004 springer_journals_10_1007_s42770_023_01153_5 |
PublicationCentury | 2000 |
PublicationDate | 2023-12-01 |
PublicationDateYYYYMMDD | 2023-12-01 |
PublicationDate_xml | – month: 12 year: 2023 text: 2023-12-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Cham |
PublicationPlace_xml | – name: Cham – name: Brazil – name: São Paulo |
PublicationTitle | Brazilian journal of microbiology |
PublicationTitleAbbrev | Braz J Microbiol |
PublicationTitleAlternate | Braz J Microbiol |
PublicationYear | 2023 |
Publisher | Springer International Publishing Springer Nature B.V |
Publisher_xml | – name: Springer International Publishing – name: Springer Nature B.V |
References | Zheng, Huang, Huang, Ye (CR11) 2020; 53 Morais, Costa, Severo, Castro (CR28) 2014; 27 Díaz-Visurraga, Cárdenas, García (CR27) 2010; 108 Elhosseiny, Elhezawy, Attia (CR4) 2019; 128 Sallam, Abou-Aisha (CR30) 2016; 9 Sertcelik, Baran, Akinci, Mumcuoglu, Bodur (CR6) 2020; 26 Voulgari, Poulou, Koumaki, Tsakris (CR9) 2013; 8 Al-Kadmy, Ibrahim, Al-Saryi, Aziz, Besinis, Hetta (CR10) 2020; 26 Laupland (CR20) 2002; 13 Lorena, Verçosa, Machado, Moitinho-Silva, Cavalcanti, Silva, Ferreira, Correa-Oliveira, Pereira, Gomes (CR17) 2008; 22 Fam, Gamal, Azmy, Wasfy, Aboul-Fadl, Badr, El-Damarawy (CR2) 2017; 26 Ono, Ito, Watanabe, Koshio, Tansho, Ikeda, Kawakami, Miyazawa (CR26) 2004; 10 Cushnie, O’Driscoll, Lamb (CR29) 2016; 73 CR31 Norrby-Teglund, Basma, Andersson, McGeer, Low, Kotb (CR21) 1998; 26 Farag, Mahran, Abou-Aisha, El-Azizi (CR15) 2013; 32 Oliveira Júnior, da Silva, Veras, Ribeiro, de Freitas, de Lima, Gutierrez, Camara, Barbosa-Filho, Alves, Brayner (CR18) 2020; 149 Machado, Araújo, Carvalho, Carvalho (CR12) 2004; 79 Mikolajczyk, Concepcion, Wang, Frazier, Golding, Frasch, Scott (CR25) 2004; 11 Morais, Costa, Almeida, Severo, Castro (CR16) 2013; 49 Wood, Jones, Soper, Nagarsheth, Creech, Thomsen (CR35) 2017; 61 CR8 CR7 Campbell, Georgiou, Kemp (CR19) 1999; 11 Basma, Norrby-Teglund, McGeer, Low, El-Ahmedy, Dale, Schwartz, Kotb (CR24) 1998; 66 CR22 Shi, Zhu, Zou, Shi, Du, Long, Wang, Xu, Zhen, Sun (CR33) 2017; 95 Tarnutzer, Andreoni, Keller, Zürcher, Norrby-Teglund, Schüpbach, Zinkernagel (CR23) 2018; 25 Tanaka, Nakae, Onoe, Horiuchi, Miyamoto, Adan-Kubo, Adachi, Ono (CR13) 2010; 16 Ahmad, Karah, Nadeem, Wai, Uhlin (CR1) 2019; 14 Ye, Li, Liu, Lei, Jiang, Wang, Zhang, Du, Cao, Ma, Li (CR14) 2018; 151 Doi, Murray, Peleg (CR3) 2015; 36 Scavuzzi, Alves, Veras, Brayner, Lopes (CR32) 2016; 65 Xiong, Estellés, Li, Abdelhady, Gonzales, Bayer, Tenorio, Leighton, Ryser (CR34) 2017; 61 Mea, Yong, Wong (CR5) 2021; 247 IMS Al-Kadmy (1153_CR10) 2020; 26 NG Morais (1153_CR28) 2014; 27 S Ye (1153_CR14) 2018; 151 A Tarnutzer (1153_CR23) 2018; 25 HJ Mea (1153_CR5) 2021; 247 1153_CR31 YQ Xiong (1153_CR34) 2017; 61 NG Morais (1153_CR16) 2013; 49 MM Sallam (1153_CR30) 2016; 9 N Farag (1153_CR15) 2013; 32 TP Cushnie (1153_CR29) 2016; 73 N Fam (1153_CR2) 2017; 26 PRL Machado (1153_CR12) 2004; 79 Y Doi (1153_CR3) 2015; 36 H Basma (1153_CR24) 1998; 66 VMB Lorena (1153_CR17) 2008; 22 Y Ono (1153_CR26) 2004; 10 I Ahmad (1153_CR1) 2019; 14 JB Oliveira Júnior (1153_CR18) 2020; 149 H Shi (1153_CR33) 2017; 95 NM Elhosseiny (1153_CR4) 2019; 128 A Norrby-Teglund (1153_CR21) 1998; 26 JY Zheng (1153_CR11) 2020; 53 1153_CR22 AML Scavuzzi (1153_CR32) 2016; 65 1153_CR7 JB Wood (1153_CR35) 2017; 61 J Díaz-Visurraga (1153_CR27) 2010; 108 E Voulgari (1153_CR9) 2013; 8 J Tanaka (1153_CR13) 2010; 16 DE Campbell (1153_CR19) 1999; 11 KB Laupland (1153_CR20) 2002; 13 A Sertcelik (1153_CR6) 2020; 26 MG Mikolajczyk (1153_CR25) 2004; 11 1153_CR8 |
References_xml | – volume: 8 start-page: 27 issue: 1 year: 2013 end-page: 39 ident: CR9 article-title: Carbapenemase-producing Enterobacteriaceae: now that the storm is finally here, how will timely detection help us fight back? publication-title: Future Microbiol doi: 10.2217/fmb.12.130 contributor: fullname: Tsakris – ident: CR22 – volume: 151 start-page: 317 year: 2018 end-page: 323 ident: CR14 article-title: In vitro evaluation of the biological activities of IgG in seven Chinese intravenous immunoglobulin preparations publication-title: J Pharm Biomed Anal doi: 10.1016/j.jpba.2018.01.021 contributor: fullname: Li – volume: 61 start-page: e00968 issue: 11 year: 2017 end-page: e1017 ident: CR35 article-title: Commercial intravenous immunoglobulin preparations contain functional neutralizing antibodies against the Leukocidin LukAB (LukGH) publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00968-17 contributor: fullname: Thomsen – volume: 22 start-page: 91 issue: 2 year: 2008 end-page: 98 ident: CR17 article-title: Cellular immune response from Chagasic patients to CRA or FRA recombinant antigens of publication-title: J Clin Lab Anal doi: 10.1002/jcla.20209 contributor: fullname: Gomes – volume: 61 start-page: 10 year: 2017 ident: CR34 article-title: Kauvar LM (2017) A Human biofilm-disrupting monoclonal antibody potentiates antibiotic efficacy in rodent models of both and infections publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00904-17 contributor: fullname: Ryser – volume: 36 start-page: 85 issue: 1 year: 2015 end-page: 89 ident: CR3 article-title: : evolution of antimicrobial resistance - treatment options publication-title: Sem Respir Crit Care Med doi: 10.1055/s-0034-1398388 contributor: fullname: Peleg – volume: 26 start-page: 631 issue: 3 year: 1998 end-page: 638 ident: CR21 article-title: Varying titers of neutralizing antibodies to Streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: implications for therapeutic efficacy publication-title: Clin Infect Dis doi: 10.1086/514588 contributor: fullname: Kotb – volume: 247 start-page: 126722 year: 2021 ident: CR5 article-title: An overview of pathogenesis: motility, adherence, and biofilm formation publication-title: Microbiol Res doi: 10.1016/j.micres.2021.126722 contributor: fullname: Wong – volume: 73 start-page: 4471 issue: 23 year: 2016 end-page: 4492 ident: CR29 article-title: Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of action publication-title: Cell Mol Life Sci doi: 10.1007/s00018-016-2302-2 contributor: fullname: Lamb – volume: 149 start-page: 104529 year: 2020 ident: CR18 article-title: Antimicrobial activity and biofilm inhibition of riparins I, II and III and ultrastructural changes in multidrug-resistant bacteria of medical importance publication-title: Microb Pathog doi: 10.1016/j.micpath.2020.104529 contributor: fullname: Brayner – ident: CR8 – volume: 26 start-page: 1 issue: 1 year: 2017 end-page: 7 ident: CR2 article-title: Antimicrobial efficacy of doripenem colistin combination on carbapenem-resistant isolates by E-test agar dilution and ultrastructural methods publication-title: Egypt J Med Microbiol doi: 10.12816/0046266 contributor: fullname: El-Damarawy – volume: 25 start-page: 512.e7 issue: 4 year: 2018 end-page: 512.e13 ident: CR23 article-title: Human polyspecific immunoglobulin attenuates group A Streptococcal virulence factor activity and reduces disease severity in a murine necrotizing fasciitis model publication-title: Clin Microbiol Infect doi: 10.1016/j.cmi.2018.07.007 contributor: fullname: Zinkernagel – volume: 26 start-page: 616 issue: 6 year: 2020 end-page: 622 ident: CR10 article-title: Prevalence of genes involved in colistin resistance in : first report from Iraq publication-title: Microb Drug Resist doi: 10.1089/mdr.2019.0243 contributor: fullname: Hetta – volume: 13 start-page: 100 issue: 2 year: 2002 end-page: 106 ident: CR20 article-title: Polyclonal intravenous immunoglobulin for the prophylaxis and treatment of infection in critically ill adults publication-title: Can J Infect Dis doi: 10.1155/2002/127953 contributor: fullname: Laupland – volume: 11 start-page: 359 issue: 5 year: 1999 end-page: 365 ident: CR19 article-title: Pooled human immunoglobulin inhibits Il-4 but not IFN-γ or TNF-α secretion following in vitro stimulation of mononuclear cells with Staphylococcal superantigen publication-title: Cytokine doi: 10.1006/cyto.1998.0435 contributor: fullname: Kemp – volume: 128 start-page: 20 year: 2019 end-page: 27 ident: CR4 article-title: Comparative proteomics analyses of strains ATCC17978 and AB5075 reveal the differential role of type II secretion system secretomes in lung colonization and ciprofloxacin resistance publication-title: Microb Pathog doi: 10.1016/j.resmic.2018.04.005 contributor: fullname: Attia – volume: 49 start-page: 84 issue: 2 year: 2013 end-page: 90 ident: CR16 article-title: Immunological parameters of macrophages infected by methicillin resistant/sensitive publication-title: J Bras Patol Med Lab doi: 10.1590/S1676-24442013000200002 contributor: fullname: Castro – volume: 10 start-page: 234 issue: 4 year: 2004 end-page: 238 ident: CR26 article-title: Opsonic activity assessment of human intravenous immunoglobulin preparations against drug-resistant bacteria publication-title: J Infect Chemother doi: 10.1007/s10156-004-0325-3 contributor: fullname: Miyazawa – ident: CR31 – volume: 79 start-page: 647 issue: 6 year: 2004 end-page: 664 ident: CR12 article-title: Immune response mechanisms to infections publication-title: An Bras Dermatol Rio de Janeiro BR doi: 10.1590/S0365-05962004000600002 contributor: fullname: Carvalho – volume: 9 start-page: 301 year: 2016 end-page: 311 ident: CR30 article-title: El-Azizi M (2016) A novel combination approach of human polyclonal IVIG and antibiotics against multidrug-resistant Gram-positive bacteria publication-title: Infect Drug Resist doi: 10.2147/IDR.S120227 contributor: fullname: Abou-Aisha – volume: 95 start-page: 1734 year: 2017 end-page: 1742 ident: CR33 article-title: Effects of specific egg yolk immunoglobulin on pan-drug-resistant publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2017.09.112 contributor: fullname: Sun – volume: 65 start-page: 1370 issue: 12 year: 2016 end-page: 1377 ident: CR32 article-title: Ultrastructural changes caused by polymyxin B and meropenem in multidrug-resistant carrying blaKPC-2 gene publication-title: J Med Microbiol doi: 10.1099/jmm.0.000367 contributor: fullname: Lopes – volume: 11 start-page: 1158 issue: 6 year: 2004 end-page: 1164 ident: CR25 article-title: Characterization of antibodies to capsular polysaccharide antigens of type b and in human immune globulin intravenous preparations publication-title: Clin Diagn Lab Immunol doi: 10.1128/CDLI.11.6.1158-1164.2004 contributor: fullname: Scott – ident: CR7 – volume: 53 start-page: 854 issue: 6 year: 2020 end-page: 865 ident: CR11 article-title: Colistin for pneumonia involving multidrug-resistant complex publication-title: J Microbiol Immunol Infect doi: 10.1016/j.jmii.2019.08.007 contributor: fullname: Ye – volume: 14 start-page: e0210082 issue: 1 year: 2019 ident: CR1 article-title: Analysis of colony phase variation switch in clinical isolates publication-title: PLoS ONE doi: 10.1371/journal.pone.0210082 contributor: fullname: Uhlin – volume: 66 start-page: 2279 issue: 5 year: 1998 end-page: 2283 ident: CR24 article-title: Opsonic antibodies to the surface m protein of group A Streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A Streptococcal infections publication-title: Infect Immun doi: 10.1128/iai.66.5.2279-2283.1998 contributor: fullname: Kotb – volume: 108 start-page: 633 issue: 2 year: 2010 end-page: 46 ident: CR27 article-title: Lethal effect of chitosan-Ag (I) films on as evaluated by electron microscopy publication-title: Microsc Sci Technol Appl Educ doi: 10.1111/j.1365-2672.2009.04447.x contributor: fullname: García – volume: 27 start-page: 557 issue: 5 year: 2014 end-page: 568 ident: CR28 article-title: Long-term effects of neonatal malnutrition on microbicidal response, cytokine production and macrophage viability in methicillin-sensitive/resistant Staphylococcus aureus infection publication-title: Rev Nutr doi: 10.1590/1415-52732014000500005 contributor: fullname: Castro – volume: 26 start-page: 429 issue: 5 year: 2020 end-page: 433 ident: CR6 article-title: Synergistic activities of colistin combinations with meropenem, sulbactam, minocycline, disodium fosfomycin, or vancomycin against different clones of carbapenem-resistant strains publication-title: Microb Drug Resist doi: 10.1089/mdr.2019.0088 contributor: fullname: Bodur – volume: 16 start-page: 383 issue: 6 year: 2010 end-page: 387 ident: CR13 article-title: Complement-mediated bacteriolysis after binding of specific antibodies to drug-resistant : morphological changes observed by using a field emission scanning electron microscope publication-title: J Inf Chemother doi: 10.1007/s10156-010-0074-4 contributor: fullname: Ono – volume: 32 start-page: 1149 issue: 9 year: 2013 end-page: 1160 ident: CR15 article-title: Assessment of the efficacy of polyclonal intravenous immunoglobulin G (IVIG) against the infectivity of clinical isolates of methicillin-resistant (MRSA) and publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-013-1861-5 contributor: fullname: El-Azizi – volume: 49 start-page: 84 issue: 2 year: 2013 ident: 1153_CR16 publication-title: J Bras Patol Med Lab doi: 10.1590/S1676-24442013000200002 contributor: fullname: NG Morais – volume: 26 start-page: 429 issue: 5 year: 2020 ident: 1153_CR6 publication-title: Microb Drug Resist doi: 10.1089/mdr.2019.0088 contributor: fullname: A Sertcelik – volume: 53 start-page: 854 issue: 6 year: 2020 ident: 1153_CR11 publication-title: J Microbiol Immunol Infect doi: 10.1016/j.jmii.2019.08.007 contributor: fullname: JY Zheng – ident: 1153_CR22 doi: 10.1093/femspd/ftx118 – volume: 247 start-page: 126722 year: 2021 ident: 1153_CR5 publication-title: Microbiol Res doi: 10.1016/j.micres.2021.126722 contributor: fullname: HJ Mea – volume: 27 start-page: 557 issue: 5 year: 2014 ident: 1153_CR28 publication-title: Rev Nutr doi: 10.1590/1415-52732014000500005 contributor: fullname: NG Morais – volume: 26 start-page: 631 issue: 3 year: 1998 ident: 1153_CR21 publication-title: Clin Infect Dis doi: 10.1086/514588 contributor: fullname: A Norrby-Teglund – volume: 108 start-page: 633 issue: 2 year: 2010 ident: 1153_CR27 publication-title: Microsc Sci Technol Appl Educ doi: 10.1111/j.1365-2672.2009.04447.x contributor: fullname: J Díaz-Visurraga – volume: 32 start-page: 1149 issue: 9 year: 2013 ident: 1153_CR15 publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-013-1861-5 contributor: fullname: N Farag – volume: 13 start-page: 100 issue: 2 year: 2002 ident: 1153_CR20 publication-title: Can J Infect Dis doi: 10.1155/2002/127953 contributor: fullname: KB Laupland – volume: 95 start-page: 1734 year: 2017 ident: 1153_CR33 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2017.09.112 contributor: fullname: H Shi – volume: 9 start-page: 301 year: 2016 ident: 1153_CR30 publication-title: Infect Drug Resist doi: 10.2147/IDR.S120227 contributor: fullname: MM Sallam – ident: 1153_CR31 doi: 10.3389/fmicb.2016.00760 – volume: 149 start-page: 104529 year: 2020 ident: 1153_CR18 publication-title: Microb Pathog doi: 10.1016/j.micpath.2020.104529 contributor: fullname: JB Oliveira Júnior – volume: 8 start-page: 27 issue: 1 year: 2013 ident: 1153_CR9 publication-title: Future Microbiol doi: 10.2217/fmb.12.130 contributor: fullname: E Voulgari – volume: 16 start-page: 383 issue: 6 year: 2010 ident: 1153_CR13 publication-title: J Inf Chemother doi: 10.1007/s10156-010-0074-4 contributor: fullname: J Tanaka – volume: 14 start-page: e0210082 issue: 1 year: 2019 ident: 1153_CR1 publication-title: PLoS ONE doi: 10.1371/journal.pone.0210082 contributor: fullname: I Ahmad – volume: 25 start-page: 512.e7 issue: 4 year: 2018 ident: 1153_CR23 publication-title: Clin Microbiol Infect doi: 10.1016/j.cmi.2018.07.007 contributor: fullname: A Tarnutzer – volume: 61 start-page: 10 year: 2017 ident: 1153_CR34 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00904-17 contributor: fullname: YQ Xiong – volume: 65 start-page: 1370 issue: 12 year: 2016 ident: 1153_CR32 publication-title: J Med Microbiol doi: 10.1099/jmm.0.000367 contributor: fullname: AML Scavuzzi – volume: 151 start-page: 317 year: 2018 ident: 1153_CR14 publication-title: J Pharm Biomed Anal doi: 10.1016/j.jpba.2018.01.021 contributor: fullname: S Ye – volume: 11 start-page: 1158 issue: 6 year: 2004 ident: 1153_CR25 publication-title: Clin Diagn Lab Immunol doi: 10.1128/CDLI.11.6.1158-1164.2004 contributor: fullname: MG Mikolajczyk – volume: 128 start-page: 20 year: 2019 ident: 1153_CR4 publication-title: Microb Pathog doi: 10.1016/j.resmic.2018.04.005 contributor: fullname: NM Elhosseiny – volume: 73 start-page: 4471 issue: 23 year: 2016 ident: 1153_CR29 publication-title: Cell Mol Life Sci doi: 10.1007/s00018-016-2302-2 contributor: fullname: TP Cushnie – ident: 1153_CR7 – volume: 79 start-page: 647 issue: 6 year: 2004 ident: 1153_CR12 publication-title: An Bras Dermatol Rio de Janeiro BR doi: 10.1590/S0365-05962004000600002 contributor: fullname: PRL Machado – volume: 22 start-page: 91 issue: 2 year: 2008 ident: 1153_CR17 publication-title: J Clin Lab Anal doi: 10.1002/jcla.20209 contributor: fullname: VMB Lorena – volume: 26 start-page: 1 issue: 1 year: 2017 ident: 1153_CR2 publication-title: Egypt J Med Microbiol doi: 10.12816/0046266 contributor: fullname: N Fam – volume: 10 start-page: 234 issue: 4 year: 2004 ident: 1153_CR26 publication-title: J Infect Chemother doi: 10.1007/s10156-004-0325-3 contributor: fullname: Y Ono – ident: 1153_CR8 doi: 10.1179/1973947812Y.0000000032 – volume: 26 start-page: 616 issue: 6 year: 2020 ident: 1153_CR10 publication-title: Microb Drug Resist doi: 10.1089/mdr.2019.0243 contributor: fullname: IMS Al-Kadmy – volume: 66 start-page: 2279 issue: 5 year: 1998 ident: 1153_CR24 publication-title: Infect Immun doi: 10.1128/iai.66.5.2279-2283.1998 contributor: fullname: H Basma – volume: 11 start-page: 359 issue: 5 year: 1999 ident: 1153_CR19 publication-title: Cytokine doi: 10.1006/cyto.1998.0435 contributor: fullname: DE Campbell – volume: 36 start-page: 85 issue: 1 year: 2015 ident: 1153_CR3 publication-title: Sem Respir Crit Care Med doi: 10.1055/s-0034-1398388 contributor: fullname: Y Doi – volume: 61 start-page: e00968 issue: 11 year: 2017 ident: 1153_CR35 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00968-17 contributor: fullname: JB Wood |
SSID | ssj0025042 |
Score | 2.3768148 |
Snippet | The high incidence of multidrug-resistant (MDR)
Acinetobacter baumannii
has been a challenge for health worldwide, due to the reduction of therapeutic options,... The high incidence of multidrug-resistant (MDR) Acinetobacter baumannii has been a challenge for health worldwide, due to the reduction of therapeutic options,... |
SourceID | pubmedcentral proquest crossref pubmed springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 2845 |
SubjectTerms | Acinetobacter baumannii Acinetobacter Infections - drug therapy Acinetobacter Infections - microbiology Amikacin Amikacin - pharmacology Amikacin - therapeutic use Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Anti-Infective Agents - pharmacology Antimicrobial agents Bacteria Bacterial diseases Bacterial infections Binding Biomedical and Life Sciences Cell morphology Clinical Microbiology - Research Paper Colistin Colistin - pharmacology Complement activation Complement system Cytology Drug Resistance, Multiple, Bacterial Drug Synergism Extravasation Fluorescence Food Microbiology Humans IgG antibody Immune system Immunofluorescence Immunoglobulin G Immunoglobulins Immunoglobulins, Intravenous - pharmacology Immunoglobulins, Intravenous - therapeutic use Infections Intravenous administration Life Sciences Medical Microbiology Meropenem Meropenem - pharmacology Meropenem - therapeutic use Microbial Ecology Microbial Genetics and Genomics Microbial Sensitivity Tests Microbiology Monocytes Morphology Multidrug resistance Multidrug resistant organisms Mycology Neutralization Opsonization Phagocytosis Scanning electron microscopy |
Title | In vitro evaluation of human intravenous immunoglobulin in combination with antimicrobials and human serum against multidrug-resistant isolates of Acinetobacter baumannii |
URI | https://link.springer.com/article/10.1007/s42770-023-01153-5 https://www.ncbi.nlm.nih.gov/pubmed/37904004 https://www.proquest.com/docview/2895760547 https://www.proquest.com/docview/2884675564 https://pubmed.ncbi.nlm.nih.gov/PMC10689330 |
Volume | 54 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELf2IdBeEJ-jMJCReAuZ2sRpnMcxARvTEJo22FtkJ86wRJMpSyexP4m_kjvbSZN2SLCXqnVcf-Tu5zuf786EvFWykKAXTP0iSrjPFFd4vhv4mQiCSSFDGRg75PGX6cEZ-3wena-tn_e8luaN3M1ubo0ruQtVoQzoilGy_0HZrlEogO9AX_gECsPnP9H4sPSudVNXvZzdRvkzhnmNZttrm4JVYxRIhck_jOO59T2HPbH9i4tva_RMm7RMmFEZ7em2HZgJOjBfCA2apHVAzOv5hQ_7dNQ9y8bTMEtUWY1Wiwf1uEhgEmhPCmyi1HpwdlyLG22sK720Fa7rgZE_Vxh_ZbRbZ-4WeA0ZLEql8D5VvdgVqLlXCzz0fw9vzgbuoCdM6Z1oqXRddRUrkCcg9dEmauvNTLPfoBADOH9Wi2MDdaPqGnoU8HKRAbVzkJkpTGzuudH1zSZBuOSC0ppNlwyvC9tfXyagIA_tHUm7ypaBjPcZG0d9QWKzYTvAsL5U4DZlptMwAm5zqa9IL-uwcsWCGG8DCtDRDQSSH_UrAwdezgw_h3FiVuCFJG-9F74e78NOn6Otap1sBrAE8w2yuXd08v2oM0ZEY3OxVDc5F1BmwkpXBrBF7re9DfW3lU3Zqm_xkoOB0dtOH5IHbsNF9yx6HpE1VT4m9-wVrL-ekN-HJTUYogsM0aqghvdpD0N0iCF4RHsYooghOsQQ_MxdOwZD1GGI3oIh2mII-x5giHYYekrOPn443T_w3f0lfgYvtPEnkSpEyEUiojgHHpyqiZIgAxloi5JjBHuBTgxj9EzgoHNMiyxgnEkVJpM8ZDx8RjbKqlTPCc0imU2CTOUCtmuFzIXMVBxLBkSZJCoZj4jXUiW9tGlq0i4huSFnCuRMDTnTaER2WsKlDulXacCTKIahsHhE3nSPQdjgCaIoFbxpqIPblSiashHZtnTuumsZZET4gAO6CpjIfvik1D9MQvuWWUfkXcssi3H9fRov7t7TS7K1WBR2yEZTz9Ur2F008rUDyh_2EzGb |
link.rule.ids | 230,315,783,787,888,27938,27939 |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+vitro+evaluation+of+human+intravenous+immunoglobulin+in+combination+with+antimicrobials+and+human+serum+against+multidrug-resistant+isolates+of+Acinetobacter+baumannii&rft.jtitle=Brazilian+journal+of+microbiology&rft.au=de+Lima%2C+Fernanda+Cristina+Gomes&rft.au=de+Ara%C3%BAjo%2C+Alberon+Ribeiro&rft.au=do+Nascimento%2C+Amanda+Vasconcelos&rft.au=Bezerra+Cavalcanti%2C+Carmelita+de+Lima&rft.date=2023-12-01&rft.pub=Springer+International+Publishing&rft.issn=1517-8382&rft.eissn=1678-4405&rft.volume=54&rft.issue=4&rft.spage=2845&rft.epage=2856&rft_id=info:doi/10.1007%2Fs42770-023-01153-5&rft_id=info%3Apmid%2F37904004&rft.externalDBID=PMC10689330 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1517-8382&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1517-8382&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1517-8382&client=summon |